Uveitis Subspecialty Day 2022 Highlights

In this interview from AAO 2022, Uveitis Subspecialty Day co-chair Dr. Lucia Sobrin provides her top highlights from the meeting. Topics include the use of expanded imaging modalities for early detection of infectious disease, as well as late-breaking news on the extension of the Systemic Immunosuppressive Therapy for Eye Disease (SITE) trial and results from the Macular Edema Ranibizumab vs. Intravitreal Anti-inflammatory Therapy (MERIT) trial.

Relevant Financial Disclosures: None.